Fulcrum Therapeutics Inc (FULC) recently have taken one step ahead with the beta value of 3.12

Steve Mayer

Fulcrum Therapeutics Inc (NASDAQ: FULC) open the trading on Wednesday, with a bit cautious approach as it glided -1.91% to $11.32, before settling in for the price of $11.54 at the close. Taking a more long-term approach, FULC posted a 52-week range of $2.32-$12.19.

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 54.59%. Meanwhile, its Annual Earning per share during the time was 54.59%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -637.50%. This publicly-traded company’s shares outstanding now amounts to $54.11 million, simultaneously with a float of $47.99 million. The organization now has a market capitalization sitting at $612.62 million. At the time of writing, stock’s 50-day Moving Average stood at $9.12, while the 200-day Moving Average is $6.43.

Fulcrum Therapeutics Inc (FULC) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Fulcrum Therapeutics Inc’s current insider ownership accounts for 11.33%, in contrast to 89.93% institutional ownership. According to the most recent insider trade that took place on Nov 19 ’25, this organization’s Director sold 15,000 shares at the rate of 11.03, making the entire transaction reach 165,495 in total value, affecting insider ownership by 484,864.

Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators

Let’s observe the current performance indicators for Fulcrum Therapeutics Inc (FULC). It’s Quick Ratio in the last reported quarter now stands at 17.70.

In the same vein, FULC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.18, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.22 at the market close of one year from today.

Technical Analysis of Fulcrum Therapeutics Inc (FULC)

[Fulcrum Therapeutics Inc, FULC] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.27% While, its Average True Range was 68.10.

Raw Stochastic average of Fulcrum Therapeutics Inc (FULC) in the period of the previous 100 days is set at 85.29%, which indicates a major rise in contrast to 82.32% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.76 that was higher than 0.57 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.